These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7437511)

  • 21. Decreased life span and membrane damage of carbamylated erythrocytes in vitro.
    Lane TA; Burka ER
    Blood; 1976 Jun; 47(6):909-17. PubMed ID: 1276471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2016 Mar; 3():CD003426. PubMed ID: 26942338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
    Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
    Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2012 Jul; (7):CD003426. PubMed ID: 22786485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003426. PubMed ID: 20091545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of irreversibly sickled cells in an animal model.
    Castro O; Cochran JD
    J Natl Med Assoc; 1978 Jan; 70(1):23-6. PubMed ID: 702541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure of Stored Packed Erythrocytes to Nitric Oxide Prevents Transfusion-associated Pulmonary Hypertension.
    Muenster S; Beloiartsev A; Yu B; Du E; Abidi S; Dao M; Fabry G; Graw JA; Wepler M; Malhotra R; Fernandez BO; Feelisch M; Bloch KD; Bloch DB; Zapol WM
    Anesthesiology; 2016 Nov; 125(5):952-963. PubMed ID: 27517645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preservation of erythrocytes of heterozygous SC sickle cell patients].
    Lasserre J; Maury J; Lefevre G; Max-Audit I; Bimet C; Maier-Redelsperger M; Etienne J; Rain JD; Adam E; Benbunan M; Girot R
    Transfus Clin Biol; 2000 Apr; 7(2):119-28. PubMed ID: 10812656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte oxidative stress markers in children with sickle cell disease.
    Hermann PB; Pianovski MA; Henneberg R; Nascimento AJ; Leonart MS
    J Pediatr (Rio J); 2016; 92(4):394-9. PubMed ID: 27117632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test.
    Kickler TS; Smith B; Bell W; Drew H; Baldwin M; Ness PM
    Transfusion; 1985; 25(5):401-5. PubMed ID: 4049483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
    Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
    Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte aging in sickle cell disease.
    Bosman GJ
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):81-6. PubMed ID: 15040431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
    Kim J; Usmani A; De Simone N; Sarode R
    Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The survival time of rabbit's erythrocytes. I. Elimination of auto- and allogenic erythrocytes radioactively labeled with chromium 51Cr from circulation.
    Szymaniec S; Steuden W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):193-6. PubMed ID: 749770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane protein phosphorylation in intact normal and sickle cell erythrocytes.
    Dzandu JK; Johnson RM
    J Biol Chem; 1980 Jul; 255(13):6382-6. PubMed ID: 7391025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of storage on erythrocyte survival in blood obtained from donors with sickle cell trait.
    LEVIN WC; TRUAX WE
    J Lab Clin Med; 1960 Jan; 55():94-7. PubMed ID: 14416237
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of ascorbic acid on glucose-6-phosphate dehydrogenase-deficient erythrocytes: studies in an animal model.
    Udomratn T; Steinberg MH; Campbell GD; Oelshlegel FJ
    Blood; 1977 Mar; 49(3):471-5. PubMed ID: 836955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.